This study investigates the use of blood proteomics to identify non-invasive biomarkers for non-small cell lung cancer (NSCLC). Researchers utilized the SomaScan and NULISA platforms to analyze protein signatures in patients undergoing surgery or immunotherapy. The findings highlight specific proteins, such as MUC16 and IL-6, which can predict tumor recurrence, treatment response, and overall surv...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动